Abstracts Archive - Page 123 of 1683 - ATC Abstracts

2022 American Transplant Congress
Race Inequity in Liver Transplant Waitlisting: Effect Modification by Psychosocial Factors and the Stanford Integrated Psychosocial Assessment for Transplant
S. Deutsch-Link¹, L. Nephew², E. Weinberg³, R. Weinrieb⁴, M. Serper³
¹Gastroenterology & Hepatology, University of North Carolina, Chapel Hill, NC, ²Gastroenterology & Hepatology, Indiana University, Chapel Hill, NC, ³Gastroenterology & Hepatology, University of Pennsylvania, Philadelphia, PA, ⁴Psychiatry, University of Pennsylvania, Philadelphia, PA
*Purpose: Race inequity in liver transplantation (LT) has been a longstanding area of injustice within the field of hepatology. Information from psychosocial evaluations and The…
2022 American Transplant Congress
Long-Term Outcomes for Living Kidney Donors with Early Guideline-Concordant Follow-Up Care
A. Dhalla¹, A. Lloyd², K. L. Lentine³, A. X. Garg⁴, R. R. Quinn¹, P. Ravani¹, S. W. Klarenbach², B. R. Hemmelgarn², U. Ibelo¹, N. N. Lam¹
¹Department of Medicine, Division of Nephrology, University of Calgary, Calgary, AB, Canada, ²Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, AB, Canada, ³Center for Abdominal Transplantation, Saint Louis University, St. Louis, MO, ⁴Department of Medicine, Division of Nephrology, Western University, London, ON, Canada
*Purpose: Current guidelines recommend that living kidney donors receive annual lifelong follow-up to monitor kidney health. It is unclear whether early guideline-concordant care is associated…
2022 American Transplant Congress
Validation of a Prediction System for Risk of Allograft Loss (iBOX) in Pediatric Kidney Transplant Recipients
J. Hogan¹, G. Divard², R. Garro³, O. Boyer⁴, M. Seifert⁵, J. Smith⁶, B. Toenshoff⁷, K. Twombley⁸, B. Warady⁹, P. Weng¹⁰, R. Zaar¹¹, R. Patzer¹², A. Loupy²
¹Pediatric Nephrology, Robert Debré Hospital, APHP, Paris, France, ²Paris Transplant Group, INSERM, Paris, France, ³Pediatric Nephrology, Children Healthcare of Atlanta, Atlanta, GA, ⁴Pediatric Nephrology, Necker Hospital, Paris, France, ⁵UAB School of Medicine, Birmingham, AL, ⁶Pediatric Nephrology, Seattle Children, Seattle, WA, ⁷University Children's Hospital, Heidelberg, Germany, ⁸Medical University of South Carolina, Charleston, SC, ⁹Childrens Mercy Hospital, Kansas City, MO, ¹⁰Pediatric Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA, ¹¹Pediatric Nephrology, Le Bonheur Children's Hospital, Memphis, TN, ¹²Emory Transplant Center, Emory University, Atlanta, GA
*Purpose: Kidney allograft loss is a common cause of end-stage renal disease but accurate prediction models of kidney allograft loss are lacking in children. The…
2022 American Transplant Congress
Acute Graft versus Host Disease (AGVHD) Related to Solid Organ Transplant (SOT) – A Fatal Complication
H. Shaikh¹, J. Awosika¹, B. Barakoti¹, B. Hambley¹, C. Alquist²
¹University of Cincinnati Medical Center, Cincinnati, OH, ²Hoxworth Blood Center, Cincinnati, OH
*Purpose: This case series highlights our institution's experience with solid-organ transplant (SOT) associated acute graft versus host disease (aGVHD), a rare and deadly complication of…
2022 American Transplant Congress
Healthcare Cost And Kidney Allocation In Liver Recipients With Kidney Disease
Y. Lu¹, X. Cheng², S. Sanoff³, L. McElroy³
¹University of Michigan, Ann Arbor, MI, ²Stanford University, Palo Alto, CA, ³Duke University, Durham, NC
*Purpose: End stage kidney disease (ESKD) in liver transplant (LT) candidates is associated with worse survival. We sought to identify the predictors of ESKD in…
2022 American Transplant Congress
CD14⁺ Monocytes Play a Critical Role in Initiating Xeno-Recognition, Costimulation and Immune-Responses to Porcine Endothelial Cells
H. Xu, A. Kirk, H. Xu
Duke University School of Medicine, Durham, NC
*Purpose: Porcine endothelial cells (PECs) are the first barrier between a pig’s organ and circulating immune system. Unlike allogeneic immune responses, PECs fail to induce…
2022 American Transplant Congress
Establishing a Framework for Long-Term Follow-Up: A Survey of Perspectives and Preferences of Living Kidney Donors
S. K. Singh¹, N. Caton², O. Johnston², C. S. Hanson³, A. Dominello³, K. Yetzer⁴, D. Chang², A. Tong³, J. S. Gill²
¹Department of Medicine, University of Toronto, Toronto, ON, Canada, ²Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ³Sydney School of Public Health, University of Sydney, Sydney, Australia, ⁴Canadian Blood Services, Ottawa, ON, Canada
*Purpose: There is currently no established standard for long-term follow-up of living kidney donors in Canada. To inform a new national standard, we sought to…
2022 American Transplant Congress
Recipient MCPggaac Haplotype is Associated with Poor Graft Survival in Recipients with De Novo Thrombotic Microangiopathy
V. Petr¹, D. Csuka², P. Hruba³, Á. Szilágyi², Z. Prohászka², O. Viklicky¹
¹Dept. of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, ²Dept. of Medicine and Hematology, Semmelweis University, Budapest, Hungary, ³Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
*Purpose: De novo thrombotic microangiopathy (TMA) is associated with poor kidney graft survival. We aimed to assess the role of common complement haplotypes in kidney…
2022 American Transplant Congress
Digital Spatial Profiling of Kidney Allograft Biopsies with Chronic Allograft Dysfunction in African American Transplant Recipients
C. R. Dorr¹, S. A. Elmer¹, B. Wu², B. Guo², J. Czyzyk², G. Crary³, G. Onyeaghala¹, W. Oetting², P. Jacobson², R. B. Mannon⁴, G. Agarwal⁵, J. Maltzman⁶, A. Matas², A. Israni³
¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²University of Minnesota, Minneapolis, MN, ³Hennepin County Medical Center, Minneapolis, MN, ⁴Medicine, University of Nebraska Medical Center, Omaha, NE, ⁵University of Alabama at Birmingham, Birmingham, AL, ⁶Stanford University, Palo Alto, CA
*Purpose: Understanding tissue heterogeneity is important to identify the molecular and cellular mechanisms of kidney allograft loss in African American (AA) transplant recipients. Our aim…
2022 American Transplant Congress
Renal Transplants In Hepatitis C Negative Recipients With Nucleic Acid Positive Donors Using Two Weeks Of DAA Prophylaxis (Rehanna – 2)
N. M. Desai¹, S. Leung¹, J. Motter¹, F. Naqvi², N. Bair¹, B. Barnaba², D. Warren¹, D. Segev¹, C. Durand²
¹Surgery, Johns Hopkins University, Baltimore, MD, ²Medicine, Johns Hopkins University, Baltimore, MD
*Purpose: To mitigate the organ shortage and underutilization of hepatitis C-infected deceased donor (HCV D+) organs, we evaluated the use of HCV D+ kidneys in…